Are patients with Werlhof's disease at increased risk for bleeding complications when undergoing cardiac surgery?

Citation
S. Christiansen et al., Are patients with Werlhof's disease at increased risk for bleeding complications when undergoing cardiac surgery?, EUR J CAR-T, 18(3), 2000, pp. 353-356
Citations number
17
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
ISSN journal
10107940 → ACNP
Volume
18
Issue
3
Year of publication
2000
Pages
353 - 356
Database
ISI
SICI code
1010-7940(200009)18:3<353:APWWDA>2.0.ZU;2-Y
Abstract
Background: It is generally assumed, that patients with Werlhof's disease ( WD) are at increased risk for bleeding complications when undergoing cardia c surgery with extracorporeal circulation. Therefore we performed this case control study to estimate the real risk for bleeding complications of thes e patients. Methods: Between 05/95 and 07/98, ten patients with WD (eight m ales, two females) underwent cardiac surgery employing extracorporeal circu lation (WD-group). Five of these patients with platelet counts below 80/nl were treated by immunoglobulins preoperatively. Each patient with WD was ma tched to five patients without WD (no-WD-group) using diagnosis, age, gende r, ejection fraction, number of distal anastomosis and body-mass-index as m atching criteria. Results: Mean number of platelet counts were significant lower in the WD-group than in the no-WD-group despite a significant increas e of platelet counts after immunoglobulin treatment (54/nl --> 112/nl, P = 0.018). On the day before, directly after and on the first day after surger y they were 141/nl vs. 215/nl (P = 0.012), 75/nl vs. 147/nl (P = 0.001) and 93/nl vs. 136/nl (P = 0.009). Accordingly, patients of the WD-group receiv ed significantly more platelet concentrates than patients of the no-WD-grou p (mean number of platelet concentrates: 2.3 versus 0.7, P = 0.007). Total drainage loss via the mediastinal chest tubes was almost identical (1197 ml in the no-WD-group and 1140 ml in the WD-group). One patient of each group suffered from a bleeding complication requiring reexploration. Three patie nts of the no-WD-group (6%) and one patient of the WD-group (10%) expired p ostoperatively unrelated to WD. Conclusions: Patients with WD may possibly undergo cardiac surgery without a markedly enhanced risk for bleeding compl ications despite a more than usual transfusion requirement and significantl y lower platelet counts perioperatively. (C) 2000 Elsevier Science B.V. All rights reserved.